{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:38:41Z","timestamp":1782952721573,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The <jats:italic>Stephanoascus ciferrii<\/jats:italic> complex, comprising <jats:italic>Stephanoascus ciferrii, Candida allociferrii<\/jats:italic>, and <jats:italic>Candida mucifera<\/jats:italic>, is an emerging fungal pathogen with increasing isolation rates and antifungal resistance. However, detailed information about clinical isolation rates and pathogenicity comparisons among the three species are lacking. In order to fill in this information gap, this study aimed to investigate and compare the clinical isolation rates and pathogenicity of the three species. Twenty-seven <jats:italic>S. ciferrii<\/jats:italic> complex strains isolated from the secretion specimens of patients admitted to Nanjing Drum Tower Hospital between 2012 and 2023 were included. According to the results of ITS sequencing, there were 15 strains of <jats:italic>S. ciferrii<\/jats:italic>, 7 strains of <jats:italic>C. allociferrii<\/jats:italic>, and 5 strains of <jats:italic>C. mucifera<\/jats:italic>. Antifungal susceptibility testing demonstrated that the <jats:italic>S. ciferrii<\/jats:italic> complex exhibited high MICs against azole antifungal agents, particularly fluconazole, while it showed lower MICs against echinocandins. <jats:italic>S. ciferrii<\/jats:italic> displayed higher MICs against caspofungin than <jats:italic>C. allociferrii<\/jats:italic> (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The results of biofilm quantification using crystal violet staining indicated <jats:italic>C. allociferrii<\/jats:italic> exhibited stronger biofilm-forming ability than <jats:italic>S. ciferrii<\/jats:italic> in RPMI-1640 medium (<jats:italic>P<\/jats:italic> &amp;lt; 0.05), but there was no significant difference between <jats:italic>C. allociferrii<\/jats:italic> and <jats:italic>C. mucifera<\/jats:italic> or between <jats:italic>S. ciferrii<\/jats:italic> and <jats:italic>C. mucifera<\/jats:italic>. The results were similar with the metabolic activity by using XTT assay. The <jats:italic>G. mellonella<\/jats:italic> larvae infection experiments revealed that the survival rates of larvae infected by strains of the <jats:italic>S. ciferrii<\/jats:italic> complex were 60%, 50%, and 48% at 24 h, 48 h, and 72 h, respectively. Furthermore, the <jats:italic>G. mellonella<\/jats:italic> larvae lethality caused by <jats:italic>C. allociferrii<\/jats:italic> and <jats:italic>C. mucifera<\/jats:italic> were significantly higher than that caused by <jats:italic>S. ciferrii<\/jats:italic> (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). This study is the first to describe and compare the pathogenicity and biofilm formation ability of the three species of <jats:italic>S. ciferrii<\/jats:italic> complex in the clinical context. Our research reveals the high prevalence of <jats:italic>S. ciferrii<\/jats:italic> in the complex and elucidates the correlation between fungal drug resistance, biofilm formation, and virulence, thus providing essential empirical evidence for further study of the clinical pathogenic characteristics of each species in the complex and treatment strategies.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1570952","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:20:41Z","timestamp":1744176041000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical isolation, biofilm formation, and pathogenicity analysis of different species of the Stephanoascus ciferrii complex"],"prefix":"10.3389","volume":"16","author":[{"given":"Shilan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"001236","DOI":"10.1099\/jmm.0.001236","article-title":"ERG11Implication of efflux pumps and genes in resistance of clinical isolates to fluconazole","volume":"70","author":"Abbes","year":"2021","journal-title":"Med. Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11046-011-9418-6","article-title":"Fluconazole-, Amphotericin-B-, Caspofungin-, and Anidulafungin-Resistant Candida ciferrii: an unknown cause of systemic mycosis in a child","volume":"172","author":"Agin","year":"2011","journal-title":"Mycopathologia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1128\/JCM.02816-12","article-title":"Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom","volume":"51","author":"Andrew","year":"2013","journal-title":"J. Clin. Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1080\/09273948.2021.1957125","article-title":"Postpartum endogenous endophthalmitis in a young immunocompetent female by a rare fungus Candida ciferrii. Ocular. Immunol. Inflamm","volume":"30","author":"Bansal","year":"2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00211-19","article-title":"Fluconazole resistance in isolates of uncommon pathogenic yeast species from the United Kingdom","volume":"63","author":"Borman","year":"2019","journal-title":"Antimicrobial Agents Chemother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat. Rev. Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.diagmicrobio.2003.08.002","article-title":"Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999","volume":"48","author":"Cheng","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","article-title":"Candida auris genetics and emergence","volume":"77","author":"Chowdhary","year":"2023","journal-title":"Annu. Rev. Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/jof10040294","article-title":"Stephanoascus ciferrii Complex: the current state of infections and drug resistance in humans","volume":"10","author":"Cosio","year":"2024","journal-title":"J. Fungi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","article-title":"Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland","volume":"48","author":"Coste","year":"2020","journal-title":"Infection"},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1574-695X.2000.tb01427.x","article-title":"Development of an insect model for the in vivo pathogenicity testing of yeasts","volume":"27","author":"Cotter","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01102886","article-title":"Prevalence of Candida ciferrii in elderly patients with trophic disorders of the legs","volume":"131","author":"de Gentile","year":"1995","journal-title":"Mycopathologia"},{"key":"B13","volume-title":"The First Case of Stephanoascus ciferrii Infection in a Newborn and Review of Literature","author":"Demiray","year":"2015"},{"key":"B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41579-022-00791-0","volume":"21","author":"Flemming","year":"2023","journal-title":"Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1383953","DOI":"10.3389\/fmicb.2024.1383953","article-title":"Antifungal activity of nisin against clinical isolates of azole-resistant Candida tropicalis","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s002770000252","article-title":"Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients","volume":"80","author":"Gunsilius","year":"2001","journal-title":"Ann. Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"680060","DOI":"10.3389\/fmicb.2021.680060","article-title":"Identification and antifungal susceptibility analysis of Stephanoascus ciferrii complex species isolated from patients with chronic suppurative otitis media","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF02098589","article-title":"Candida ciferrii, a new yeast species","volume":"26","author":"Kreger-Van Rij","year":"1965","journal-title":"J. Mycopathol Mycol Appl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1099\/00207713-52-2-463","article-title":"Species distinction of the ascomycetous heterothallic yeast-like fungus Stephanoascus ciferrii complex: description of Candida allociferrii sp. nov., and reinstatement of Candida mucifera Kockov\u00e1-Kratochv\u00edlov\u00e1 et Sl\u00e1vikov\u00e1","volume":"52","author":"Kumiko","year":"2002","journal-title":"J. Syst. Evol. Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10529-023-03432-5","article-title":"Biofilm development of Candida boidinii and the effect of tyrosol on biofilm formation","volume":"45","author":"Marton","year":"2023","journal-title":"Biotechnol. Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1534\/g3.119.400762","article-title":"Genome assemblies of two rare opportunistic yeast pathogens: Diutina rugosa (syn. Candida rugosa) and Trichomonascus ciferrii (syn. Candida ciferrii). G3 (Bethesda)","volume":"9","author":"Mix\u00e3o","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/17460913.2024.2342150","article-title":"Antifungal resistance: why are we losing this battle?","volume":"19","author":"Paiva","year":"2024","journal-title":"Fut. Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/jac\/dkz231","article-title":"Antifungal susceptibility profiles of rare ascomycetous yeasts","volume":"74","author":"P\u00e9rez-Hansen","year":"2019","journal-title":"J. Antimicrob. Chemother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0158322","DOI":"10.1128\/spectrum.01583-22","article-title":"Functional characterization of a bacillus-derived novel broad-spectrum antifungal lipopeptide variant against Candida tropicalis and Candida auris and unravelling its mode of action","volume":"11","author":"Ramesh","year":"2023","journal-title":"Microbiol. Spectr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"104889","DOI":"10.1016\/j.micpath.2021.104889","article-title":"The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia","volume":"155","author":"Sasani","year":"","journal-title":"Microb. Pathog"},{"key":"B27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.21203\/rs.3.rs-377398\/v1","article-title":"Virulence factors and azole-resistant mechanism of Candida tropicalis isolated from Candidemia","volume":"186","author":"Sasani","year":"","journal-title":"Mycopathologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/tropicalmed7090211","article-title":"Prevalence and antifungal susceptibility of clinically relevant Candida species, identification of Candida auris and Kodamaea ohmeri in Bangladesh","volume":"7","author":"Sathi","year":"2022","journal-title":"Trop. Med. Infect. Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","article-title":"Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris","volume":"23","author":"Sherry","year":"2017","journal-title":"Emerg. Infect. Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother"},{"key":"B31","doi-asserted-by":"publisher","first-page":"638609","DOI":"10.3389\/fmicb.2021.638609","article-title":"Mechanistic understanding of Candida albicans biofilm formation and approaches for its inhibition","volume":"12","author":"Tanu","year":"2021","journal-title":"Front. Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.00577-18","article-title":"Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study","volume":"56","author":"Xiao","year":"2018","journal-title":"J. Clin Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1012225","DOI":"10.1371\/journal.ppat.1012225","article-title":"Biofilm-associated metabolism via ERG251 in Candida albicans","volume":"20","author":"Xiong","year":"2024","journal-title":"PLoS Pathog"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1570952\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:20:42Z","timestamp":1744176042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1570952\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":33,"alternative-id":["10.3389\/fmicb.2025.1570952"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1570952","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"article-number":"1570952"}}